Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide for Blood Pressure Control in Peritoneal Dialysis Patients
NCT07271420Phase 4Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Change in systolic and diastolic blood pressure at 90 days. Started Jan 2020; status: recruiting.
02
Drugs
hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07271420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07271420.